RESUMEN
INTRODUCTION: Nonalcoholic steatohepatitis (NASH) is one of the most common etiologies of liver transplantation (LT) in the United States. We investigated regional trends in waitlist candidates, LT rates, and recipient survival among patients with NASH. METHODS: Using the United Network for Organ Sharing database by Organ Procurement and Transplantation Network regions, we investigated waitlist registration, LT rates, and survival for NASH between January 2004 and December 2019. RESULTS: The absolute number and percentage of total LT performed for NASH increased substantially in all Organ Procurement and Transplantation Network regions. In 2019, region 11 had the highest percentage of NASH-related LT with 31.4% followed by region 10 (25.3%) and region 8 (23.1%). Between 2015 and 2019, region 5 had the highest rising percentage in LT for NASH at 208%, followed by region 1 (194%) and region 4 (183%). The proportion of NASH hepatocellular carcinoma (NASH-HCC) was the highest in region 9 at 37.7% and lowest in region 10 (19.2%), region 3 (20.6%), and region 11 (20.8%). In multivariate analysis, diabetes (HR 1.18, P < 0.001), dialysis before LT (hazard ratio [HR] 1.53, P < 0.001), HCC (HR 1.19, P < 0.00), portal vein thrombosis (HR 1.24, P < 0.001), donor age (HR 1.026, P = 0.03), and recipient age (HR 1.24, P = <0.001) were associated with worse survival. DISCUSSION: LT for patients with NASH has dramatically increased across all regions since 2004, but with substantial heterogeneity among regions in the proportion with HCC and post-LT survival. Identifying contributing factors to these regional differences is warranted.
Asunto(s)
Carcinoma Hepatocelular , Neoplasias Hepáticas , Trasplante de Hígado , Enfermedad del Hígado Graso no Alcohólico , Carcinoma Hepatocelular/epidemiología , Carcinoma Hepatocelular/cirugía , Humanos , Enfermedad del Hígado Graso no Alcohólico/epidemiología , Enfermedad del Hígado Graso no Alcohólico/cirugía , Estudios Retrospectivos , Factores de Riesgo , Estados Unidos/epidemiologíaRESUMEN
Objectives. To compare the severity of inpatient hospitalizations between undocumented immigrants and Medi-Cal patients in a large safety-net hospital in Los Angeles, California. Methods. We conducted a retrospective analysis of all 2019 inpatient stays at a Los Angeles hospital (n = 22 480), including patients of all races/ethnicities. We examined 3 measures by using insurance status to approximate immigration status: illness severity, length of hospital stay, and repeat hospitalizations. We calculated group differences between undocumented and Medi-Cal patients by using inverse probability weighted regression adjustment separately for patients aged 18 to 64 years and those aged 65 years and older. Results. Younger undocumented patients had less severe illness and shorter lengths of stay than their Medi-Cal counterparts. Older undocumented immigrants also had less severe illness, but had similar lengths of stay and were more likely to have repeated hospitalizations. Conclusions. While existing work suggests that undocumented immigrants could have more severe health care needs on account of their poorer access to medical care, we did not see clear health disadvantages among hospitalized undocumented immigrants, especially younger patients. There were fewer differences between undocumented and Medi-Cal patients who were older. (Am J Public Health. 2021;111(11):2019-2026. https://doi.org/10.2105/AJPH.2021.306485).
Asunto(s)
Hospitalización/estadística & datos numéricos , Inmigrantes Indocumentados , Adolescente , Adulto , Anciano , Femenino , Accesibilidad a los Servicios de Salud , Necesidades y Demandas de Servicios de Salud , Humanos , Cobertura del Seguro , Tiempo de Internación/estadística & datos numéricos , Los Angeles , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Factores de Riesgo , Índice de Severidad de la Enfermedad , Planes Estatales de SaludAsunto(s)
Carcinoma Hepatocelular , Encefalopatía Hepática , Neoplasias Hepáticas , Trasplante de Hígado , Derivación Portosistémica Intrahepática Transyugular , Carcinoma Hepatocelular/cirugía , Humanos , Neoplasias Hepáticas/cirugía , Derivación Portosistémica Intrahepática Transyugular/efectos adversosRESUMEN
Content available: Author Audio Recording.
RESUMEN
Syphilis is a sexually transmitted disease that can affect multiple organ systems, with central nervous system involvement at any stage. We present a 53-year-old woman with an unusual truncal rash with painful anogenital lesions, accompanied by patchy alopecia, oral lesions, photophobia and hoarseness. She was found to have positive serological tests for syphilis with cerebrospinal fluid findings suggestive of neurosyphilis. She underwent a 14-day course of intravenous penicillin G and exhibited successful resolution of painful anogenital lesions as well as marked improvement in dermatological, oropharyngeal, laryngeal, and neurological symptoms.
Asunto(s)
Ronquera/diagnóstico , Neurosífilis/diagnóstico , Sífilis Cutánea/diagnóstico , Alopecia/complicaciones , Alopecia/diagnóstico , Alopecia/tratamiento farmacológico , Alopecia/patología , Antibacterianos/uso terapéutico , Enfermedades del Ano/complicaciones , Enfermedades del Ano/diagnóstico , Enfermedades del Ano/tratamiento farmacológico , Enfermedades del Ano/patología , Femenino , Cefalea/etiología , Ronquera/tratamiento farmacológico , Ronquera/etiología , Humanos , Enfermedades de la Laringe/complicaciones , Enfermedades de la Laringe/diagnóstico , Enfermedades de la Laringe/tratamiento farmacológico , Persona de Mediana Edad , Enfermedades de la Boca/complicaciones , Enfermedades de la Boca/diagnóstico , Enfermedades de la Boca/tratamiento farmacológico , Enfermedades de la Boca/patología , Neurosífilis/líquido cefalorraquídeo , Neurosífilis/complicaciones , Neurosífilis/tratamiento farmacológico , Paladar Duro , Penicilina G/uso terapéutico , Fotofobia/etiología , Sífilis Cutánea/tratamiento farmacológico , Sífilis Cutánea/patología , Enfermedades de la Vulva/complicaciones , Enfermedades de la Vulva/diagnóstico , Enfermedades de la Vulva/tratamiento farmacológico , Enfermedades de la Vulva/patologíaRESUMEN
PURPOSE: Both hormone therapy (HT) and antiretroviral therapy (ART) can be lifesaving for transgender women (TW) living with HIV, but each has side effects and potential drug-drug interactions (DDI). We assessed how concerns about HT-ART interactions affect treatment adherence. METHODS: This study used a cross-sectional survey of TW (n = 87) in Los Angeles, CA. RESULTS: Fifty-four percent were living with HIV; 64% used HT. Only 49% of TW living with HIV discussed ART-HT DDI with their provider; 40% reported not taking ART (12%), HT (12%), or both (16%) as directed due to DDI concerns. CONCLUSION: Imperfect HT/ART use and limited provider communication suggests a need for improved HT-ART integration.